MACH-1
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Aug 2024)
What this means for you
This application is over — abandoned 19 Aug 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90033606
- Mark type
- Stylized text
- Filed
- 02 Jul 2020
- Published for opposition
- 18 May 2021
- Abandoned
- 19 Aug 2024
- Attorney of record
- Connie L. Ellerbach
Goods and services
- Class 005 — Pharmaceuticals: vaccines; vaccine preparations; medical preparations for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; pharmaceutical preparations and substances for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for the treatment of diseases affecting mucosal tissues, the immune system, respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes
- Class 042 — Scientific and technological services: research and development of vaccines; research and development of medicines; medical research; scientific research; clinical research; all in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy
- Class 044 — Medical, beauty and agricultural services: medical services; medical testing for treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical evaluation services of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; medical treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes
Owner
- Orlance, Inc., Seattle, WA, US
- Orlance, Inc., Seattle, WA, US
Prosecution history
- 19 Aug 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Aug 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jan 2024 — SOU EXTENSION 5 GRANTED
- 29 Dec 2023 — SOU EXTENSION 5 FILED
- 18 Jan 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Dec 2023 — SOU TEAS EXTENSION RECEIVED
- 20 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2023 — SOU EXTENSION 4 GRANTED
- 16 Jun 2023 — SOU EXTENSION 4 FILED
- 16 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 13 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jan 2023 — SOU EXTENSION 3 GRANTED
- 11 Jan 2023 — SOU EXTENSION 3 FILED
- 11 Jan 2023 — SOU TEAS EXTENSION RECEIVED